Identify The Best Sites, Activate Faster, And Enroll Sooner
Today’s clinical research leaders need to streamline every phase of clinical trial timelines. Ryght’s agentic AI platform makes it easier than ever to find, qualify, and activate high-potential sites faster.
Make it to market faster
Compress Development Timelines
Faster site selection, qualification and activation can compress overall development timelines by 6-12 months per study. For blockbuster drugs, this acceleration can translate to hundreds of millions in additional revenue through earlier market entry.
Maximize Study Success Rates
Ryght AI's precision AI matching ensures optimal alignment between your protocol requirements and site capabilities, leading to higher enrollment rates, better data quality, and reduced study failure risk – protecting your R&D investment.
Enable Portfolio-Wide Optimization
Leverage comprehensive site performance data across your entire development portfolio to identify high-performing sites for future studies, negotiate better terms, and build strategic long-term partnerships that benefit multiple programs.
Lower costs, accelerate collaboration with your CRO, and enroll patients sooner.
Direct platform access means you retain full control over site selection decisions without intermediary interpretation or potential misalignment of priorities. Make real-time adjustments and strategic pivots as your program evolves.
Cut expensive CRO fees and lengthy vendor negotiations. Our AI-powered platform gives you direct access to instant protocol analysis, site identification and feasibility management, reducing reliance on external resources and saving hundreds of thousands in vendor costs per study.
Skip the months-long site identification process. Our platform instantly scans 100,000 AI digital twins to deliver optimal site matches in minutes, not months, dramatically reducing internal resource allocation and project management overhead.
Advanced AI matching prevents costly site selection errors that lead to poor enrollment, protocol deviations, and study failures. Avoid the expensive consequences of re-screening sites, extending timelines, or adding backup locations mid-study.
Explore the Ryght platform
Leverage AI-powered digital twins to instantly analyze every research site around the globe and reveal the locations that best match your protocol’s needs.
Automatically send qualified sites pre-populated feasibility questionnaires powered by data from our AI digital twin network. Track and compare all responses in real-time.
Available on the Microsoft Azure Marketplace
Ryght is available on Microsoft Azure Marketplace, making it easy for sponsors and CROs to use existing cloud commitments, simplify billing, and increase cost efficiency.
Discover the difference AI-powered site selection and feasibility can make.
We understand why you might be skeptical, which is why we’re ready to demonstrate Ryght’s capabilities for you in real time.
Just give us twenty minutes and an old protocol, and we'll show you how quickly Ryght finds the best-fit sites for your trial before you finish your coffee.
Test Ryght on an old protocol to see how we stack up.
Related resources
Navigating the Life Sciences Landscape: A Conversation with Tom Pike
Ryght's LinkedIn Live session uncovers the forefront of industry trends on the transformative potential of generative AI and its profound impact on shaping tomorrow's medical landscape.
Stay Connected
Subscribe to be the first to know about product updates, news and announcements.